Financhill
Sell
40

BCLI Quote, Financials, Valuation and Earnings

Last price:
$0.60
Seasonality move :
24.38%
Day range:
$0.60 - $0.63
52-week range:
$0.52 - $2.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
27K
Avg. volume:
14.7K
1-year change:
-58.9%
Market cap:
$6.6M
Revenue:
--
EPS (TTM):
-$1.46

Earnings Data

Next earnings date for BCLI
Mar 31
2026
Most recent earnings per share
-$0.19
Beat by $0.20
(Nov 14/2025)
Consensus Estimate
-$0.39
(Nov 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BCLI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q4 -- -- -- -$0.43 --
11/14/2025 Q3 -- -- -$0.19 -$0.39 $0.20
08/14/2025 Q2 -- -- -$0.34 -$0.33 -$0.01
05/14/2025 Q1 -- -- -$0.45 -$0.97 $0.52
03/31/2025 Q4 -- -- -$0.48 -$0.27 -$0.21
11/14/2024 Q3 -- -- -$0.51 -$0.70 $0.19
08/14/2024 Q2 -- -- -$0.54 -$0.45 -$0.09
05/14/2024 Q1 -- -- -$0.79 -- --
03/29/2024 Q4 -- -- -$1.66 -$1.65 -$0.01
11/14/2023 Q3 -- -- -$0.42 -- --
08/14/2023 Q2 -- -- -$2.01 -- --
05/15/2023 Q1 -- -- -$2.07 -- --
03/30/2023 Q4 -- -- -$2.05 -- --
11/14/2022 Q3 -- -- -$2.82 -- --
08/15/2022 Q2 -- -- -$2.89 -- --
05/16/2022 Q1 -- -- -$2.21 -- --
03/28/2022 Q4 -- -- -$2.56 -- --
11/15/2021 Q3 -- -- -$2.20 -- --
08/05/2021 Q2 -- -- -$2.59 -- --
04/26/2021 Q1 -- -- -$2.79 -- --
02/03/2021 Q4 -- -- -$5.53 -- --
10/15/2020 Q3 -- -- -$2.16 -- --
08/05/2020 Q2 -- -- -$3.79 -- --
05/07/2020 Q1 -- -- -$4.28 -- --
02/17/2020 Q4 -- -- -$4.98 -- --
11/14/2019 Q3 -- -- -$3.80 -- --
08/13/2019 Q2 -- -- -$3.39 -- --
05/10/2019 Q1 -- -- -$3.61 -- --
03/29/2019 Q4 -- -- -$3.89 -- --
10/29/2018 Q3 -- -- -$2.25 -- --
07/23/2018 Q2 -- -- -$2.40 -- --
05/14/2018 Q1 -- -- -$1.80 -- --
03/08/2018 Q4 -- -- $0.22 -- --
10/17/2017 Q3 -- -- -$1.95 -- --
08/16/2017 Q2 -- -- -$0.90 -- --
05/15/2017 Q1 -- -- -$1.50 -- --
03/16/2017 Q4 -- -- -$0.50 -- --
11/15/2016 Q3 -- -- -$1.35 -- --
08/11/2016 Q2 -- -- -$0.75 -- --
05/12/2016 Q1 -- -- -$1.50 -- --
03/09/2016 Q4 -- -- -$1.05 -- --

Brainstorm Cell Therapeutics, Inc. Earnings Questions

  • How Much did Brainstorm Cell Therapeutics, Inc. Generate in Revenue Last Quarter?

    Brainstorm Cell Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Brainstorm Cell Therapeutics, Inc. Beat Earnings Last Quarter?

    Brainstorm Cell Therapeutics, Inc. announced earnings per share of -$0.19 which represents a beat of analyst forecast a -$0.39 per share.

  • Is Brainstorm Cell Therapeutics, Inc. Profitable?

    Brainstorm Cell Therapeutics, Inc. reported -$48K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Brainstorm Cell Therapeutics, Inc. EPS Next Year?

    Brainstorm Cell Therapeutics, Inc.'s earnings are forecast to decrease from -$2.31 per share to -$2.10 per share next year representing a decrease of -30.44%.

  • When is Brainstorm Cell Therapeutics, Inc.'s Earnings Date?

    Brainstorm Cell Therapeutics, Inc.'s next earnings date is March 31, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
50
TGL alert for Dec 8

Treasure Global, Inc. [TGL] is up 15.64% over the past day.

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 38.25% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 8.52% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock